Connection

Haibo Qiu to Gastrointestinal Stromal Tumors

Back to Details
This is a "connection" page, showing publications Haibo Qiu has written about Gastrointestinal Stromal Tumors.
Haibo Qiu
Connection Strength
3.680
Gastrointestinal Stromal Tumors
  1. Advanced gastrointestinal stromal tumor patients benefit from palliative surgery after tyrosine kinase inhibitors therapy. Medicine (Baltimore). 2018 Jan; 97(2):e9097.
    View in: PubMed
    Score: 0.668
  2. [Updates on adjuvant therapy in gastrointestinal stromal tumor]. Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Sep 25; 20(9):961-965.
    View in: PubMed
    Score: 0.656
  3. [Association between genetic polymorphisms and variation of imatinib pharmacokinetics in gastrointestinal stromal tumors]. Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Sep 25; 20(9):1031-1034.
    View in: PubMed
    Score: 0.656
  4. Performance of risk stratification systems for gastrointestinal stromal tumors: A multicenter study. World J Gastroenterol. 2019 Mar 14; 25(10):1238-1247.
    View in: PubMed
    Score: 0.182
  5. A new nomogram for recurrence-free survival prediction of gastrointestinal stromal tumors: Comparison with current risk classification methods. Eur J Surg Oncol. 2019 Jun; 45(6):1109-1114.
    View in: PubMed
    Score: 0.179
  6. Clinicopathological Outcomes and Prognosis of Elderly Patients (= 65 Years) with Gastric Gastrointestinal Stromal Tumors (GISTs) Undergoing Curative-Intent Resection: a Multicenter Data Review. J Gastrointest Surg. 2019 05; 23(5):904-913.
    View in: PubMed
    Score: 0.176
  7. A Novel Pathological Prognostic Score (PPS) to Identify "Very High-Risk" Patients: a Multicenter Retrospective Analysis of 506 Patients with High Risk Gastrointestinal Stromal Tumor (GIST). J Gastrointest Surg. 2018 12; 22(12):2150-2157.
    View in: PubMed
    Score: 0.174
  8. Tumor necrosis and >20 mitoses per 50 high-power fields can distinguish 'very high-risk' and 'highest-risk' within 'high-risk' gastric gastrointestinal stromal tumor. Future Oncol. 2018 Mar; 14(7):621-629.
    View in: PubMed
    Score: 0.168
  9. Can therapeutic drug monitoring increase the safety of Imatinib in GIST patients? Cancer Med. 2018 02; 7(2):317-324.
    View in: PubMed
    Score: 0.167
  10. Prognostic role of tumor necrosis in patients undergoing curative resection for gastric gastrointestinal stromal tumor: a multicenter analysis of 740 cases in China. Cancer Med. 2017 Dec; 6(12):2796-2803.
    View in: PubMed
    Score: 0.165
  11. Ki-67 labeling index may be a promising indicator to identify "very high-risk" gastrointestinal stromal tumor: a multicenter retrospective study of 1022 patients. Hum Pathol. 2018 04; 74:17-24.
    View in: PubMed
    Score: 0.164
  12. Simultaneous quantification of imatinib and its main metabolite N-demethyl-imatinib in human plasma by liquid chromatography-tandem mass spectrometry and its application to therapeutic drug monitoring in patients with gastrointestinal stromal tumor. Biomed Chromatogr. 2017 Dec; 31(12).
    View in: PubMed
    Score: 0.163
  13. Dual Targeting of Insulin Receptor and KIT in Imatinib-Resistant Gastrointestinal Stromal Tumors. Cancer Res. 2017 09 15; 77(18):5107-5117.
    View in: PubMed
    Score: 0.162
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.